SHENZHEN, China, July 9 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS.PK) www.htdsmedical.com - announced today and as previously released on June 24, 2009, the Company is in the process of reasserting its ownership rights to certain intellectual property, which was inappropriately converted by the previous management of HTDS. 100% of the ownership rights are expected to be assigned back to HTDS. The following SEC filing http://www.pinksheets.com/edgar/GetFilingHtml?FilingID=652915 dated June 2, 2000 together with the activities of certain X employees and the aforementioned technology is the scope of the IP ownership rights and benefits'.
The IP rights are being utilized by a fully reporting OTCBB publicly traded company. As a result of HTDS IP rights, this company has raised over $14 million in equity financing, constructed an operating plant that generates revenue, is in the process of purchasing parcels of property in various States in order to construct additional plants and has had numerous industrial bonds approved for an average amount of $10 million each.
Once the rights have been reasserted by HTDS, various projections (based on confidential financial documents and projections of the OTCBB company) indicates gross revenue exceeding $250 million, gross profit exceeding $220 million and net income exceeding $40 million within two years.
HTDS management will decide the direction of the IP division shortly after the ownership rights have been finalized.
In other corporate news, the company advises its readers and followers that this IP ownership legal issue is separate and in addition to the partial distribution HTDS is entitled to as a beneficiary recipient in a slander lawsuit vs Investorshub.Com recently awarded in a Canada court proceeding. See link for details. http://www.minamargroup.com/client_interests.php
Additionally, HTDS will shortly be posting a legal opinion on its Adequate Disclosure Documents filed with Pink Sheets on June 2, 2009, in aid of obtaining a "Current Issuer" ranking.
The company will provide further details as they become available.
Safe Harbor Statement
Information in this news release may contain statements about future expectations, plans, prospects or performance of Hard To Treat Diseases Inc that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. Hard To Treat Diseases Inc cautions you that any forward-looking information provided by or on behalf of Hard To Treat Diseases Inc is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard To Treat Diseases Inc's actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard To Treat Diseases Inc's control. In addition to those discussed in Hard To Treat Diseases Inc's press releases, public filings, and statements by Hard To Treat Diseases Inc's management, including, but not limited to, Hard To Treat Diseases Inc's estimate of the sufficiency of its existing capital resources, Hard To Treat Diseases Inc's ability to raise additional capital to fund future operations, Hard To Treat Diseases Inc's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Hard To Treat Diseases Inc's capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard To Treat Diseases Inc does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.
|SOURCE Hard to Treat Diseases|
Copyright©2009 PR Newswire.
All rights reserved